journal article·2024-07

Glycocalyx‐Mimicking Nanoparticles with Differential Organ Selectivity for Drug Delivery and Therapy

Dohyeon Kim, Chang‐Hee Whang, Jungwoo Hong, Monica Celine Prayogo, Wonsik Jung, Seojung Lee, Hocheol Shin, Yujin Kim, Jiyoung Yu, Min Joong Kim, Kyunggon Kim, Hee‐Seung Lee, Sangyong Jon

Advanced Materials· Volume 36· Issue 27
Publisher page

Abstract

Abstract Organ‐selective drug delivery is expected to maximize the efficacy of various therapeutic modalities while minimizing their systemic toxicity. Lipid nanoparticles and polymersomes can direct the organ‐selective delivery of mRNAs or gene editing machineries, but their delivery is limited to mostly liver, spleen, and lung. A platform that enables delivery to these and other target organs is urgently needed. Here, a library of glycocalyx‐mimicking nanoparticles (GlyNPs) comprising five randomly combined sugar moieties is generated, and direct in vivo library screening is used to identify GlyNPs with preferential biodistribution in liver, spleen, lung, kidneys, heart, and brain. Each organ‐targeting GlyNP hit show cellular tropism within the organ. Liver, kidney, and spleen‐targeting GlyNP hits equipped with therapeutics effectively can alleviate the symptoms of acetaminophen‐induced liver injury, cisplatin‐induced kidney injury, and immune thrombocytopenia in mice, respectively. Furthermore, the differential organ targeting of GlyNP hits is influenced not by the protein corona but by the sugar moieties displayed on their surface. It is envisioned that the GlyNP‐based platform may enable the organ‐ and cell‐targeted delivery of therapeutic cargoes.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Liver physiology and pathology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biological Sciences KAIST Institute of BioCentury Korea Advanced Institute of Science and Technology (KAIST) 291 Daehak‐ro Daejeon 34141 Republic of Korea

Center for Precision Bio‐Nanomedicine KAIST 291 Daehak‐ro Daejeon 34141 Republic of Korea

Department of Chemistry KAIST 291 Daehak‐ro Daejeon 34141 Republic of Korea

Center for Multiscale Chiral Architectures (CMCA) KAIST 291 Daehak‐ro Daejeon 34141 Republic of Korea

Department of Convergence Medicine Asan Medical Center 88, Olympic‐ro Seoul 05505 Republic of Korea

Department of Digital Medicine College of Medicine University of Ulsan 88, Olympic‐ro Seoul 05505 Republic of Korea

Funding

Ministry of Science and ICT, South Korea

References (49)

Show source-provided references
1. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
2. 10.1038/s41565-020-0669-610.1038/s41565-020-0669-6 ↗
3. 10.1038/s41551-023-01030-410.1038/s41551-023-01030-4 ↗
4. 10.1002/adma.20230168610.1002/adma.202301686 ↗
5. 10.1002/anie.20160845010.1002/anie.201608450 ↗
6. 10.1073/pnas.210925611810.1073/pnas.2109256118 ↗
7. 10.1126/sciadv.abf439810.1126/sciadv.abf4398 ↗
8. 10.1039/C6BM00921B10.1039/C6BM00921B ↗
9. 10.3389/fcell.2020.0025310.3389/fcell.2020.00253 ↗
10. 10.1038/nri256910.1038/nri2569 ↗
11. 10.1073/pnas.160806911310.1073/pnas.1608069113 ↗
12. 10.1002/adfm.20191003110.1002/adfm.201910031 ↗
13. 10.1002/adma.20220399310.1002/adma.202203993 ↗
14. 10.1002/anie.20230481510.1002/anie.202304815 ↗
15. 10.1021/cb700178s10.1021/cb700178s ↗
16. 10.1021/acs.bioconjchem.5b0049210.1021/acs.bioconjchem.5b00492 ↗
17. 10.1016/j.jconrel.2015.02.02210.1016/j.jconrel.2015.02.022 ↗
18. 10.1002/cbic.20160002310.1002/cbic.201600023 ↗
19. 10.1089/nat.2018.073610.1089/nat.2018.0736 ↗
20. Sridhar V. S. · Am. J. Physiol. · 2019 · 317
21. 10.1111/j.1365-2796.2006.01746.x10.1111/j.1365-2796.2006.01746.x ↗
22. 10.1126/science.aat912010.1126/science.aat9120 ↗
23. 10.1038/nri166910.1038/nri1669 ↗
24. 10.1073/pnas.070377810410.1073/pnas.0703778104 ↗
25. 10.1146/annurev-physiol-052521-12184110.1146/annurev-physiol-052521-121841 ↗
26. 10.1038/nature1830010.1038/nature18300 ↗
27. 10.1021/jacs.1c0982210.1021/jacs.1c09822 ↗
28. 10.1016/j.jhep.2017.07.00510.1016/j.jhep.2017.07.005 ↗
29. 10.1002/adtp.20220022310.1002/adtp.202200223 ↗
30. 10.3389/fimmu.2022.89365910.3389/fimmu.2022.893659 ↗
31. 10.1161/JAHA.121.02121210.1161/JAHA.121.021212 ↗
32. 10.1016/j.biomaterials.2021.12098610.1016/j.biomaterials.2021.120986 ↗
33. 10.1016/j.jconrel.2021.01.01910.1016/j.jconrel.2021.01.019 ↗
34. 10.1016/j.jconrel.2020.07.01510.1016/j.jconrel.2020.07.015 ↗
35. 10.1016/j.biomaterials.2017.04.02910.1016/j.biomaterials.2017.04.029 ↗
36. 10.1016/j.biomaterials.2017.06.01410.1016/j.biomaterials.2017.06.014 ↗
37. 10.1016/j.biomaterials.2017.04.01110.1016/j.biomaterials.2017.04.011 ↗
38. 10.1002/anie.20160252510.1002/anie.201602525 ↗
39. 10.1038/s41563-019-0462-910.1038/s41563-019-0462-9 ↗
40. 10.1152/ajpendo.00405.202010.1152/ajpendo.00405.2020 ↗
41. 10.1016/j.redox.2018.04.01910.1016/j.redox.2018.04.019 ↗
42. 10.1111/j.1478-3231.2011.02501.x10.1111/j.1478-3231.2011.02501.x ↗
43. 10.1007/s40620-017-0392-z10.1007/s40620-017-0392-z ↗
44. 10.1038/nrc216710.1038/nrc2167 ↗
45. 10.1056/NEJMcp181047910.1056/NEJMcp1810479 ↗
46. 10.1182/blood-2008-07-16643910.1182/blood-2008-07-166439 ↗
47. 10.1111/bjh.1248010.1111/bjh.12480 ↗
48. 10.1186/s13045-014-0072-610.1186/s13045-014-0072-6 ↗
49. 10.1016/j.xpro.2020.10008610.1016/j.xpro.2020.100086 ↗